Loading clinical trials...
Loading clinical trials...
The purpose of the Multi-National Gilenya Pregnancy Exposure Registry in Multiple Sclerosis (MS) is to continuously monitor, evaluate, and assess for major and minor teratogenic effects in the offspri...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Novartis Pharmaceuticals
NCT06433752 · Relapsing Multiple Sclerosis, Multiple Sclerosis
NCT06846281 · Relapsing Multiple Sclerosis
NCT05644522 · Cerebrovascular Accident, Post-polio Syndrome, and more
NCT07497399 · Multiple Sclerosis
NCT06847724 · Relapsing Multiple Sclerosis
Novartis Investigative Site
Fort Lauderdale, Florida
Novartis Investigative Site
Cambridge, Massachusetts
Novartis Investigative Site
Grand Forks, North Dakota
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions